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Structural Plasticity of Functional Actin:
Pictures of Actin Binding Protein
and Polymer Interfaces
Two actin filament models have been proposed.
Holmes et al. (1990) constructed a filament using the
atomic coordinates of the actin-DNase I complex fitted
to X-ray fiber diffraction patterns obtained from oriented
F(ilamentous)-actin gels. In this widely accepted model,
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around each other in a right-handed helix. However,Faculty of Medicine and Health Sciences
Ghent University Schutt et al. argue that the ribbon like polymer, as ob-
served in the actin profilin crystal (Schutt et al., 1993),A. Baertsoenkaai 3
B-9000, Gent could be the naturally occurring state of F-actin. The
Holmes model was further refined by Lorenz et al. (1993),Belgium
resulting in the identification of more extensive contacts
between protomers, and was favored after an evaluation
by Mendelson and Morris (1994). However, as pointedSummary
out by Mounier and Sparrow (1997), there is no in vivo
evidence for either of the two models.Actin is one of the most conserved and versatile pro-
Mutational analysis of actins has been hampered be-teins capable of forming homopolymers and inter-
cause of its absolute requirement for the chaperoninacting with numerous other proteins in the cell. We
CCT (cytosolic chaperonin containing TCP-1) to reachperformed an alanine mutagenesis scan covering the
its native state (Gao et al., 1992; Rommelaere et al.,entire -actin molecule. Somewhat surprisingly, the
1993) and has been largely restricted to Drosophila andmajority of the mutants were capable of reaching a
yeast actin (Hennessey et al., 1993). In particular, for thestable conformation. We tested the ability of these
latter, the studies by Holtzman et al. (1994) and Wertmanmutants to bind to various actin binding proteins,
et al. (1992) show that actin mutations may specificallythereby mapping different interfaces with actin. Addi-
impair the interaction with an actin binding protein. How-tionally, we tested their ability to copolymerize with
ever, these studies focused on clusters of charged resi--actin in order to localize regions in actin that contact
dues only and analysis of genetic interactions. To probeneighboring protomers in the filament. Hereby, we
the actin molecule and some of its functions more com-could discriminate between two existing models for
pletely, we performed an alanine scan threading throughfilamentous actin and our data strongly support the
the entire -actin molecule substituting each time fiveright-handed double-stranded helix model. We pres-
consecutive amino acids. We established easy and reli-ent data corroborating this model in vivo. Mutants de-
able protocols for probing physical interactions of thesefective in copolymerization do not colocalize with the
mutants. As proof of principle, we tested the capacityactin cytoskeleton and some impair its normal func-
of each of these mutants to bind to DNase I. We nexttion, thereby disturbing cell shape.
compared data obtained from an interaction scan with
adseverin, with data obtained from the crystal structures
Introduction of actin in complex with gelsolin segments. Additionally,
we assayed thymosin 4 and CAP to identify interaction
Actin is the major component of the microfilament sys- regions in actin for these proteins. Finally, we investi-
tem of eukaryotic organisms. As such, it plays a central gated the ability of these actin mutants to copolymerize
role in cell motility processes. Actin is one of the most with -actin. The data allowed us to evaluate the two
conserved proteins known today, and it is thought that existing models for the actin filament structure and are
its conserved nature reflects its strict structural require- most consistent with the Holmes F-actin model. By ex-
ment to interact with itself as well as with a variety of pression of selected actin mutants in eukaryotic cells
other proteins that modulate the transition between and we also provide evidence that this model applies to
the dynamics of the monomeric and polymeric state. the in vivo situation. In some cases noncopolymerizing
For some actin binding proteins such as DNase I, profilin mutants seem to act as filament cappers thereby affect-
I, gelsolin, and the vitamin D binding protein, cocrystal ing cell morphology.
structures exist (Kabsch et al., 1990; Schutt et al., 1993;
McLaughlin et al., 1993; Robinson et al., 1999; Otterbein
et al., 2002). For other actin modulator proteins, like Results and Discussion
thymosin , the contact sites within actin have been
proposed based on crosslinking and/or electron micros- For radioactively labeled wild-type actin produced in in
copy (EM) data (Safer et al., 1997; Ballweber et al., 2002). vitro transcription translation reactions, interaction with
However, for the multitude of actin binding proteins various actin binding proteins can be monitored by a
(such as cyclase associated protein [CAP]) there are band-shift assay (Figure 1A) where an upward or down-
almost no data on actin interaction sites. ward shift of native monomeric actin can be observed,
if after translation an actin binding protein is added. We
note that relatively weak interactions (i.e., thymosin 4:*Correspondence: heidi.rommelaere@ugent.be
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may play a role in folding or may be important for gener-
ating a stable actin molecule. The chaperone interaction
of these mutants will be described elsewhere (K.N. et
al., unpublished data). We used the mutants that fold
to investigate the interaction of actin with various actin
binding proteins or with neighboring actin molecules in
the filament.
The Alanine-Scan Mutants Allow Probing
Interfaces with Actin Binding Proteins
To validate our assumption on band-shifting actin mu-
tants, we first investigated binding to DNase I, since the
contact sites in actin for this protein are known from
the crystal structure. The major contact site consists of
two loops in subdomain 2: the DNase binding loop 39–46
and the neighboring loop 61–64. The minor site is the
loop containing residues 203–207 in subdomain 4
(Kabsch et al., 1990). Results of our band-shift assay
show that actins mutated in the region 35–44 and 60–69
do not bind to DNase I, and actin mutated in region
45–49 binds less effective. Thus, this corresponds well
with the major contacts observed in the actin-DNase
complex (Figure 2A). However, actins mutated in region
203–207 are still able to bind to DNase, suggesting this
region is less important in the contact, in agreement
with the crystal structure.
We next investigated the actin binding protein adsev-
erin. This gelsolin family member consists, like gelsolin,
of six segments (S1–S6), has Ca2-dependent actin
binding activity and is capable of binding two actin mo-
nomers (Robbens et al., 1998). In gelsolin, this occurs
via S1 and via S4 as judged from crystal structures of
monomeric actin either with S1 or with S4–S6 (McLaugh-
Figure 1. Actin Alanine Mutants, Folding Capacity, and Binding to lin et al., 1993; Robinson et al., 1999). Both segments
Actin Binding Proteins
interact with actin in a similar way by extensive contacts
(A) Autoradiogram of a native gel analysis of 35S-labeled -actin or with subdomain 3 (residues 143, 144, 146–148, 167, 169,
-actin 60(A5) produced in an in vitro transcription translation reac-
296, 334) and additional contacts with subdomain 1 (res-tion (control), band shifted with either thymosin 4, DNase I, or
idues 341, 345–346, 349–351, 354–355). If similar interac-adseverin. Band shifts are also generated for interactions with rela-
tively low KD values (e.g., thymosin 4). It is, however, important tions hold for adseverin, our scan should reveal analo-
that the actin binding protein is, like actin, attracted by the anode. gous regions. This is indeed what we observe. Using
(B) 3D structure of the actin fold (Kabsch et al., 1990) with in green adseverin in the presence of Ca2, no band shifts are
those regions that, when mutated, cause folding defective mutants. generated when regions 145–154, 165–169, and 295–299
In the right panel, the actin molecule is rotated by 180. ATP is in
in subdomain 3 are mutated (Figure 2B). The mutantsyellow.
345(A5) and 350(A5) in subdomain 1 however did shift,
but this may be due to the conserved character of the
substitutions (the contacting residues are Ile, Leu, Ser,KD 5 M) can be monitored using this assay. We rea-
soned that, if the binding information for an actin binding and Thr). Also, for 330(A5) a shift is observed, probably
because Asp334 contributes little to the contact given itsprotein in an actin mutant is removed or perturbed, such
a band shift should not occur. We created 75 -actin distance from the gelsolin molecule. Reduced binding is
also seen for actins mutated in the regions 135–139,mutants in which we systematically replaced five con-
secutive amino acids by alanine (Table 1). We expressed 300–304, 335–339, and 370–375. The latter four regions
are spatially close to the interface residues and likelythese mutants in reticulocyte lysates, which endoge-
nously contain the actin folding machines prefoldin and disturb local actin architecture (e.g., 300–304 is a central
 strand in subdomain 3). Thus, these data on adseverinCCT (Gao et al., 1992; Rommelaere et al., 1993; Vainberg
et al., 1998), and analyzed the 35S-labeled products via binding are in good agreement with the crystal contacts
observed for gelsolin and suggest that adseverin con-native polyacrylamide gel electrophoresis. Fifty out of
seventy-five mutants are able to fold and four remain tacts actin in a similar way as gelsolin, which is consis-
tent with the conservation of the actin binding residuesassociated with cyclase associated protein (CAP, see
below and Table 1). In Figure 1B we show the regions in of these proteins. Surprisingly, mutants 30(A5) and
50(A5) also produce no band shift. The mutated regionsthat, when replaced by five alanines, cause folding de-
fective actin molecules. As expected, these regions map are located in subdomain 2, thus at the opposite site of
the gelsolin S1 and S4 interface in actin. We suggestmainly to the interior of the actin structure. These regions
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that reduced binding of these mutants results from the CAP binding. Either as noticed above for other actin
binding proteins, mutants show diminished binding or,conformational coupling that exists between the DNase
I binding loop and the actin C terminus (Crosbie et al., by contrast, some display a very pronounced increase
in signal on native gels at the position of the actin-CAP1994). Although possible allosteric communication be-
tween subdomains may complicate analysis, we con- complex (Figure 3A, lane 2). Folding competent actin
molecules, with mutations in regions 140–154, 165–170,clude from the results with DNase I and adseverin that
we can extract binding information for actin binding 280–299, 310–314, 335–339, 345–354, 365–374 do not
bind to CAP suggesting that subdomains 1 and 3 formproteins with our band-shift assay, but only major con-
tacts will be discovered and, not surprisingly, local con- a large binding interface (Figure 3B; Table 1), which
appears very similar to the vitamin D binding proteinformational changes may affect binding.
interaction site (Otterbein et al., 2002). However, muta-
tion of residues 35–39 and 65–69 also influences CAPAn Extended Interface with Thymosin 4
interaction. We note that the CAP-actin complex canNext we embarked on investigating proteins of which
bind to DNase I, but at higher DNase I concentration,the interface with actin is controversial or unknown. So
CAP is chased from this complex (Figure 3A, lanes 3far, it has been impossible to obtain actin thymosin 
and 4). This again indicates allosteric communicationcrystals, but various models exist for the actin thymosin
between subdomains 2 and 1 similar to what was ob-
 interaction. The band-shift assay results show com-
served above for adseverin. Mutations in subdomainpromized binding for actins mutated in the regions 35–
2 may freeze actin in a conformation incompetent for39, 60–74, 140–149, 194–198, 204–209, 300–304, 335–
allowing interactions of actin binding proteins with the339, and 350–354 (Figure 2C). Mapped on the actin
subdomain 1-3 binding cleft.molecule, this reveals a remarkably extended area con-
sistent with the elongated structure proposed for thy-
Actins Mutated in the ATP Binding Pocketmosin 4 in contact with actin (De La Cruz et al., 2000
Remain CAP Arrested[see Figure 8]; Safer et al., 1997). However, different
In the absence of ATP, CAP binding is increased forfrom these studies, we do not find an interaction with
actin mutants 70(A5) 155(A5), 160(A5), 179(A5), 210(A5),the acidic actin N terminus. Thymosin4 is even capable
and 300(A5) (Figure 3C; Table 1). Of these mutants, theof stabilizing the conformation of two inherently unsta-
latter five even bind to CAP when ATP is present in theble actin N-terminal deletion mutants (Rommelaere et
gels, whereas under these conditions, no complex isal., 1999; Figure 2D). Based on two different crosslinking
observed for wild-type actin and other folding capableexperiments, the N terminus of thymosin  is positioned
mutants. We observe normal binding to CAP when resi-near the subdomain 1-3 junction of actin (Safer et al.,
dues 15–19 and 135–139 are mutated whereas mutating1997; Reichert et al., 1996). Our results suggest that
residues surrounding these regions generates actinsthymosin 4 binds between the helices 135–144 (subdo-
that do not bind to CAP. Interestingly, all these regionsmain 3) and 338–348 (subdomain 1) and passes across
are located in or close to the ATP binding pocket of actin,the actin ATP binding pocket toward the cleft between
and contain residues 16, 18, 137, 157–159, 213–214, andsubdomains 2 and 4. Whereas this mode of binding
302–303, which are all involved in divalent ion and ATPdeviates from the model proposed by Safer et al. (1997)
binding (Kabsch et al., 1990). This arrest on CAP maywith respect to the proposed interaction with the actin
have serious effects on living cells since analogous mu-N terminus, it is in agreement with the results of Reichert
tants in yeast [154(A3), 210(A2), and 213(A3)] produceet al. (1996) where thiol specific reagents were used to
lethal or temperature sensitive phenotypes (Wertman etcouple cysteine mutants of thymosin  to the C terminus
al., 1992) and mutating residues G156, G301 or G302 inof actin and to ATPS. Also a recent model based on
the flight muscle actin of Drosophila result in abnormalcryo-EM pictures of forced polymers of thymosin cross-
myofibrils (An and Mogami, 1996). Additional residueslinked actin positions thymosin 4 close to the ATP-
involved in nucleotide interaction are 11, 14, 154, 305–cleft in actin (Ballweber et al., 2002 [see Figure 8B]).
306, and 336 (Kabsch et al., 1990). However actins withAlthough our results do not allow mapping exactly the
these residues mutated [10(A5), 150(A5), 305 (A5) andthymosin  binding interface, they allow discrimination
335 (A5)] fail to form CAP complexes. Most probably,between different proposed binding models, obtained
this is due to the fact that they are mutated close to or inby other biochemical methods.
the CAP interface or that they do not fold, since mutating
single residues in one of the regions (D11A and S14A,
Cyclase-Associated Protein, CAP, Interacts McCormack et al., 2001) results in increased CAP
with Actin in the Cleft between binding.
Subdomains 1 and 3 Our results indicate CAP binding is sensitive to the
The band-shift assays above were performed in the nucleotide state of actin, hence CAP may be an actin
presence of ATP. When ATP is omitted from the native binding protein involved in the stabilization of nucleotide
gels, a new 35S-labeled actin species, representing a free actin. Alternatively, a more active contribution of
complex between actin and endogenous CAP, appears CAP in the actin folding pathway (Gao et al., 1992; Rom-
in between the CCT-actin complex and hemoglobin (Fig- melaere et al., 1993; Vainberg et al., 1998) could be that
ure 3A, lane 1; McCormack et al., 2001; mass spectrome- it acts as an ATP-loading machine post-CCT. Thus, the
try showed this is indeed an actin-CAP complex, data actin alanine mutants provide important information on
not shown). During the analysis of our actin mutants, the actin interaction site with CAP and suggest clues
on CAP function.we observed two phenotypes with respect to altered
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Table 1. Summary of the Folding Capacity of Actin Alanine Mutants and Binding to DNAse I, Adseverin, Thymosin 4, and CAP
Mutant AA Changed Folds DNAse I Adsev Thym 4 CAP
actb(WT)     
actb2(A3) DDD     
actb5(A5) IAALV     
actb10(A5) VDNGS     
actb15(A5) GMCKA   weak  
actb20(A5) GFAGD     
actb25(A5) DAPRA     weak
actb30(A5) VFPSI   weak  
actb35(A5) VGRPR   /  
actb40(A5) HQGVM     weak
actb45(A5) VGMGQ  /   
actb50(A5) KDSYV   weak  
actb55(A5) GDEAQ     
actb60(A5) SKRGI     
actb65(A5) LTLKY   /  
actb70(A5) PIEHG     
actb75(A5) IVTNW     
actb80(A5) DDMEK     
actb85(A5) IWHHT     
actb90(A5) FYNEL   weak  
actb95(A5) RVAPE     
actb100(A5) EHPVL ()   weak weak
actb105(A5) LTEAP   weak  
actb110(A5) LNPKA     
actb115(A5) NREKM   /  
actb120(A5) TQIMF     
actb125(A5) ETFNT   ?  
actb130(A5) PAMYV     weak
actb135(A5) AIQAV   /  
actb140(A5) LSLYA    † 
actb145(A5) SGRTT     
actb150(A5) GIVMD ()    
actb155(A5) SGDGV CAP    
actb160(A5) THTVP     
actb165(A5) IYEGY     
actb170(A5) ALPHA     weak
actb175(A5) ILRLD     
actb179(A5) DLAGR ()  weak  
actb184(A5) DLTDY     
actb189(A5) LMKIL     
actb194(A5) TERGY     
actb199(A5) SFTTT     
actb204(A6) AEREIV     
actb210(A5) RDIKE CAP    
actb215(A5) KLCYV     
actb220(A5) ALDFE     
actb225(A5) QEMAT     
actb230(A5) AASSS     
actb235(A5) SLEKS     
actb240(A5) YELPD     
actb245(A5) GQVIT     
actb250(A5) IGNER     
actb255(A5) FRCPE     
actb260(A5) ALFQP     
actb265(A5) SFLGM     
actb270(A5) ESCGI     
actb275(A5) HETTF     
actb280(A5) NSIMK     weak
actb285(A5) CDVDI     
actb290(A5) RKDLY     
actb295(A5) ANTVL     
actb300(A5) SGGTT CAP  weak  
actb305(A5) MYPGI     
actb310(A5) ADRMQ ()    
actb315(A5) KEITA     
actb320(A5) LAPST     
actb325(A5) MKIKI     
(continued)
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Table 1. Continued
Mutant AA Changed Folds DNAse I Adsev Thym 4 CAP
actb330(A5) IAPPE     
actb335(A5) RKYSV   /  
actb340(A5) WIGGS     
actb345(A5) ILASL     
actb350(A5) STFQQ     weak
actb355(A5) MKISK     
actb360(A5) QEYDE     
actb365(A5) SGPSI     
actb370(A6) VHRKCF   weak  
 indicates that the mutant folds or interacts with the listed binding protein; () indicates only a small part of the population is folded; /
is reduced binding. CAP indicates the mutant is arrested on cyclase associated protein even in the presence of atp.
 indicates lack of folding or binding
 and  indicate increased CAP binding.
In Vitro Actin Polymerization Supports F-actin models have been proposed which we will refer
to as the Holmes model and the ribbon model. The firstthe Holmes F-Actin Model
Since we could locate regions in actin important for model is based on low-resolution diffraction data of
oriented F-actin filaments (Holmes et al., 1990) and isinteraction with actin binding proteins, we hypothesized
that we could also identify actin-actin contacts between widely accepted because it is consistent with numerous
biochemical experiments (e.g., Steinmetz et al., 1998).neighboring protomers in the actin filament. Two major
Figure 2. Residues of Actin Important for Binding to DNase I, Adseverin, and Thymosin 
(A–C) 3D structures of actin showing a comparison of our interaction scan results (upper molecules) with data from X-ray structures (lower
molecules, Kabsch et al., 1990; McLaughlin et al., 1993; Robinson et al., 1999) or models. The regions important for interaction with the
respective actin binding proteins are indicated in pink.
(A) The DNase I interface, (B) the gelsolin/adseverin S1 and S4 interfaces (pink: mutants with loss of binding, blue: mutants with reduced
binding), (C) model of thymosin 4 interaction, pink: our results, blue: crosslinked residues (Safer et al., 1997), green: thiol crosslinked residues
(Reichert et al., 1996), P represents the -phosphate moiety of ATP-S.
(D) Thymosin 4 is able to bind to actin lacking its N terminus. Autoradiogram of a native gel analysis of 35S-labeled actin(1–5) (lanes 1 and
2) and actin(1–6) (lanes 3 and 4) produced in an in vitro transcription translation reaction, band shifted with thymosin 4 (lanes 2 and 4).
Note these mutants are unstable and only form a discrete band when complexed to thymosin 4 (compare with wild-type actin in Figure 1A).
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However, the ribbon model is intriguing because it is
observed in the high-resolution profilin-actin crystal
structure (Schutt et al., 1993). In the Holmes model, actin
protomers are associated in two strings wound around
each other in a right-handed helix, with interactions
along and across the strands. The interactions between
molecules along one strand involve contacts between
subdomain 4 and subdomain 2 of one protomer with
subdomain 3 of the next. Contacts across the two
strands are made between subdomain 1 of one protomer
and subdomain 4 of the other and by the so-called hy-
drophobic plug which inserts into a hydrophobic pocket
(Holmes et al., 1990; for a detailed list of residues in-
volved see legend of Figure 4A). In the ribbon model
(Schutt et al., 1993), subdomain 4 and the upper part of
subdomain 2 of one protomer contact subdomain 1 and
the lower part of subdomain 2 of the next (Figure 4B).
Regions common to the two models are 40–45, 60–64,
202–205, and 243–245; thus these regions are not infor-
mative for discrimination. The main differences between
the models are, however, that in the ribbon subdomain
1 is involved in the contact whereas in the Holmes model
this is subdomain 3 with additionally the hydrophobic
plug contact (Figures 4A and 4B; Table 2). More con-
crete, residues involved in the Holmes but not in the
ribbon model are 39, 110–112, 166–169, 171, 173, 195–
197, 266–270, 285–289, 322–325, and 375 and vice versa
residues involved in the ribbon but not in the Holmes
model are 2–5, 48–50, 87–97, 99–100, 130–131, and
353–360.
To distinguish between the two models, we tested if
the actin alanine mutants were able to copolymerize
with purified -skeletal muscle actin. Two mutants
[100(A5) and 310(A5)] were prone to aggregation during
the assay suggesting decreased stability. They are not
taken up in the argumentation below. All nondiscrimina-
tive mutants (i.e., in the region 60–69, 199–203, 204–209,
and 240–244) are defective or affected in copolymeriza-
tion. More importantly, mutations in the regions 35–39,
165–169, 194–199, 285–289, and 325–329 solely pre-
dicted in the Holmes model, lead to loss in copolymer-
ization [35(A5), 165(A5) and 285(A5)], or result in reduced
copolymerization capacity [194(A5) and 325(A5); Table
2; Figure 4C]. By contrast, mutants in the region 45–49,
50–54, 95–99, 130–134, and 350–354, characteristic for
the contacts in the ribbon model, display wild-type or
nearly wild-type copolymerization capacity [mutants
Figure 3. CAP Binds in the Subdomain 1–3 Cleft of Actin and Mutat- 85(A5), 90(A5) and 355(A5) do not fold]. Thus, these
ing Residues Involved in ATP Binding Stabilizes the CAP Actin Inter- results strongly favor the Holmes model. Moreover, actin
action mutants 35(A5) en 285(A5) appear to act as filament
(A) Autoradiogram of a native gel analysis without ATP of 35S-labeled capping molecules when transfected in eukaryotic cells
actin (lane 1) and actin 155(A5) (lanes 2-4) produced in an in vitro
(see below), suggesting actin 35(A5) is crucial at thetranscription translation reaction. DNase I can form a ternary com-
pointed and actin 285(A5) at the barbed end, which canplex with the actin-CAP complex (lane 3, 0.25 nM DNaseI added)
only be explained in the Holmes model. We also findor can compete with CAP for actin binding when added at higher
concentrations (lane 4, 8.25 nM DNaseI added). CAP is dimeric impaired copolymerization capacity for mutants in re-
(unpublished observation), hence can bind two actin molecules re- gions structurally close to a major contact in the Holmes
sulting in two shifts with DNase I. Note that in gels without ATP, model. Possibly mutations in these neighboring regions
folded actin does not run as a discrete band. influence correct positioning of the F-actin contacts. For(B) Actins with mutation in one of the purple colored regions in the
instance, mutants 275(A5), 280(A5), 290(A5), and 295(A5)3D-structure show decreased binding to CAP suggesting the latter
are close to the 285–289 loop and mutants 145(A5) andbinds in the cleft between subdomains 1 and 3.
(C) Actins with mutation in one of the regions indicated in pink 150(A5) comprize a core  strand in subdomain 3 that
show increased binding to CAP. These regions are involved in ATP is close to the predicted Holmes contact regions 166–
binding. 169 and 171–173. Similarly, mutating the region 220-224
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may influence correct positioning of the hydrophobic
plug. Also, the reduced copolymerization capacity of
184(A5), having mutations in the core of a helix, can be
explained this way. However, at present it is not clear
whether this mutation affects the correct positioning of
the F-actin contact 195–197 at the end of this helix or
loop 266–272 that is structurally nearby. Only the behav-
ior of the mutant 2(A3) does not fit the Holmes model
and this region is actually a predicted ribbon model
contact. This mutant has reduced copolymerization ac-
tivity, which we currently cannot explain. However we
stress that the other discriminating mutants, covering
major contacts predicted in the ribbon model, are fully
capable of polymer formation.
The severity of the copolymerization phenotypes of
the actin mutants correlate well with the critical contacts
proposed in the Holmes model. Changing residues in
regions participating simultaneously in contacts along
and across the helix (residues in the intersections of the
blue and green circles in Figure 4A) result consistently
in mutants that are dramatically compromised in copoly-
merization. Actin mutants with substitutions of residues
involved in only one type of contact are either severely,
or little or not affected in their copolymerization capac-
ity. This observation may indicate that the latter regions
are less important for polymer formation. We often find
that mutations in regions, adjacent to proposed contact
sites in the Holmes model, also cause defective copoly-
merization. This may be suggestive of more extensive
contacts as proposed in the refined version of the
Holmes model (Lorenz et al., 1993). In addition, we note
that, in fitting the actin X-ray structure to the 8.4 A˚ fiber
diffraction data, domain movements were allowed
(Holmes et al., 1990) and in the subsequent refined
model, loops were rebuilt (Lorenz et al., 1993).
In summary, our results from the in vitro copolymeriza-
Figure 4. Actin Residues Important for Polymerization
(A and B) 3D representation of actin with highlighted in pink the
residues important in the F-actin contacts according to the two
F-actin models.
(A) In the right-handed helix model of Holmes et al. (1990), interac-
tions between molecules along one strand involve contacts between
subdomain 4 and subdomain 2 of one protomer with subdomain 3
of the next, i.e., residues 243–245 contact 322–325, 202–204 contact
286–289, and 41–45 contact 166–169 and 375 (blue circles). Arg 39
is possibly involved in a salt bridge with Asp 286 and Glu 270, each
in a different actin molecule. Contacts across the two strands occur
between subdomain 1 residues 110–112 of one protomer and 195–
197 in subdomain 4 of the other (black circles). In addition a loop,
the so called hydrophobic plug (266–269) is suggested to insert
across the helix into a hydrophobic pocket formed by residues 166,
169, 171, 173, 285, 289 and residues 40–45, 63 and 64 of two adja-
cent protomers in one strand (green circles).
(B) In the zigzag ribbon model (Schutt et al., 1993), residues 40–42,
44–46, and 60–64 of subdomain 2 of one protomer contact residues
2, 4, 5, 99, 100, 130, 131, 353, 358, and 360 of subdomain 1 of the
next (green circles). In addition residues 202, 204, 205, and 243–247
of subdomain 4 from the lower protomer contact residues 48, 50,
87, 91, 92, 95, and 97 of subdomain 2 of the upper (blue circles).
(C) 3D representation of actin showing regions important for copoly-
merization as deduced from our in vitro copolymerization assay.
Alanine substitutions of the colored regions result in actin mutants
that do not copolymerize (pink) or that have reduced copolymeriza-
tion activity (blue).
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tion assays can best be explained in terms of the Holmes Table 2. Copolymerization Capability of Actin Alanine Mutants
that Foldmodel for the actin filament (or the Lorenz version of it).
The experiments also illustrate the power of our ap- Mutant Copol Holmes Ribbon
proach in complementing and validating modeling data,
actb(WT) performed at lower resolution range.
actb2(A3) / X
actb25(A5) 
actb35(A5)  /
In Vivo Evidence for the Holmes F-Actin Model actb40(A5)  X X
The copolymerization assay above inherently uses a actb45(A5)  / X
actb50(A5) / /large excess of carrier wild-type actin and does not allow
actb55(A5) investigation of more subtle effects on actin filaments.
actb60(A5)  X XMoreover, as yet, there is no evidence that in vivo poly-
actb65(A5) / 
mer contacts are the same as those predicted from actb80(A5) 
the models (Mounier and Sparrow, 1997). Therefore, we actb95(A5)  X
investigated the behavior of selected Myc-tagged actin actb110(A5)  X
actb130(A5)  Xmutants in NIH3T3, NG108, or Hek293T cells. Only the
actb135(A5) results for NIH3T3 cells are shown, but all cell types
actb140(A5) gave similar results. The actin cytoskeleton was stained
actb145(A5) /
with phalloı¨din-alexa red, and the actin mutants were actb150(A5) 
detected with an anti-Myc FITC antibody. As a control actb160(A5) 
we introduced Myc-tagged wild-type actin, which nicely actb165(A5)  X
actb170(A5)  Xincorporates in the actin filaments (Figure 5A), also the
actb175(A5) copolymerizing 345(A5) mutant colocalizes with actin
actb184(A5) /filaments (Figure 5B). Mutants 60(A5), 35(A5), 285(A5),
actb189(A5)
145(A5), and 295(A5), defective in copolymerization in actb194(A5) / X
vitro and fitting the Holmes model, do not colocalize with actb199(A5)  X X
actin filaments (Figures 5C–5G). By contrast, mutants actb204(A6)  / X
actb220(A5) /95(A5) and 350(A5), that do copolymerize (see above)
actb225(A5) and cover predicted contacts in the ribbon model, are
actb230(A5) incorporated in filaments (Figures 5H and 5I). Trans-
actb235(A5) 
fected cells expressing the polymerization defective mu- actb240(A5)  X X
tants 145(A5) and 295(A5), which have mutations in re- actb245(A5)  / X
gions peripheral to the contacts proposed in the Holmes actb250(A5) 
actb265(A5)  Xmodel, have a normal cytoskeleton and shape (Figures
actb270(A5)  /5F and 5G). For mutants in the interaction regions, we
actb275(A5) observed different phenotypes with regard to actin cy-
actb280(A5) 
toskeleton and cell shape. Mutants 60(A5) and 35(A5) actb285(A5)  X
induce in many cases formation of densely stained actin actb290(A5) 
fibers in the center of the cells with some residual F-actin actb295(A5) 
actb315(A5) staining in a punctuate pattern in case of mutant 35(A5)
actb320(A5)  X(Figures 5C, 5D, and 6). The dense short actin fibers
actb325(A5) / /formed in 60(A5) transfected cells are not in the nucleus,
actb330(A5) 
as can be seen in Figure 6C. The nucleus itself appears actb335(A5) 
also reduced and deformed. In most cases, the trans- actb345(A5) 
fected cells are much smaller and rounded, likely due actb350(A5)  X
actb365(A5) to the collapse of the actin cytoskeleton, which may
actb370(A6)  /explain why most of these transfectants were lost after
48 hr. Cells transfected with 285(A5) seem to have an X indicates that several amino acids in this region are involved in
the Holmes, respectively ribbon model, / indicates that only oneintermediate phenotype. They are again much smaller
amino acid in this region is involved.and we observed reduced staining of F-actin fibers, al-
 indicates folded mutants that do not copolymerize.though the effect on the cytoskeleton is less severe
/, /, and / indicate different levels of reduced copoly-compared to cells transfected with mutants 60(A5) and
merization activity.
35(A5) (Figure 5E). At present, we can only speculate on
the cause of this severe phenotype. On the one hand
an interaction with an organizing actin binding protein
may be compromised, but perhaps more likely, the dis- the Holmes model predicts that regions 35–39 and 60–64
are at the minus end and 285–289 is at the plus end,turbance of the cytoskeleton is caused by a continu-
ously filament capping action of these mutants. Indeed, our in vivo data again support this model. Unfortunately,
our in vitro polymerization assay described above wasregions 35–49 and 60–64, and 285–289 are on opposite
sides of the actin protomer and, if located in an F-actin not sensitive enough to detect capping activity for actin
60(A5) and 285(A5), however for 35(A5) we noticed cap-contact, mutants in these regions may behave as actin
filament capping proteins and will affect actin dynamics ping activity in vitro (data not shown). The results ob-
tained with the latter mutants may also explain the tem-with pointed end mutants having a stronger effect. As
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perature sensitivity, respectively lethality of the yeast
actin mutants 37(A3), 61(A2), and 286(A3) (Wertman et
al., 1992) and the disruption of indirect flight muscle
fibers by the G63D mutation in Drosophila (An and Mo-
gami, 1996). Mutating the 93–95 and the 99–100 regions
in yeast also results in a strong phenotype, although
we do not observe defects in copolymerization for the
95(A5) mutant. In this case the effects observed in yeast
(and also in Drosophila) are probably caused by the
fact that myosin and/or fimbrin binding contacts are
disturbed (Wertman et al., 1992; Holtzman et al., 1994;
Razzaq et al., 1999). The severity of disrupting these
contacts is likely dependent on the cell type or on the
growth conditions.
In summary, both our in vitro and in vivo experiments
support the Holmes model for actin filaments.
Conclusion
In view of the conservation of actin, it is remarkable
that so many regions of this molecule can be changed
without having deleterious effects in vitro. Indeed only
a minority of the mutants does not fold or is extremely
unstable suggesting larger than expected structural
plasticity of the actin molecule. Therefore, the reason
for this extreme conservation may indeed be the number
of different interactions actin participates in. Hence our
mutants are important tools for extracting binding infor-
mation on interaction with its partners, as we did for
adseverin, thymosin, CAP and actin itself. Additionally,
the mutants can be helpful in gathering information on
the function of actin binding partners, since we found,
unexpectedly, that CAP may stabilize nucleotide free
actin. With regard to actin filament contacts, our results
show that actins mutated in contact regions predicted
in the Holmes model fail to copolymerize in vitro and
do not colocalize with endogenous actin in cells and, in
some cases, even disturb the actin cytoskeleton. On the
other hand mutants in predicted ribbon contacts appear
to have no effects on cell morphology and colocalize
with the endogenous actin. In addition, by creating these
mutants and developing an analysis system we estab-
lished a platform to address more easily questions with
respect to actin mutants in muscle diseases like dilated
cardiomyopathy (Olson et al., 1998), and nemaline my-
opathy (Nowak et al., 1999; Ilkovski et al., 2001) or actin
mutants associated with neutrophil dysfunction (Nunoi
et al., 1999) or tumorigenesis (Lin et al., 1985). Obviously,
it would be interesting to investigate the supra-molecu-
lar structure of filaments harboring mutant actin mole-Figure 5. In Vivo Evidence for the Holmes Model
cules, by electron microscopy or their effect on actinExpression of N-terminally Myc-tagged actin alanine mutants in NIH
dynamics. However, given the relatively low levels of3T3 cells. Western blotting of lysates of transfected cells and prob-
protein produced in the transcription/translation assaying with mouse anti-Myc antibodies revealed the presence of actins
with the correct molecular weight (data not shown). (A) Wild-type this is a future objective, as these experiments require
actin, (B) actin 345(A5), (C) actin 60(A5), (D) actin 35(A5), (E) actin generating sufficient amounts of mutant actin.
285(A5), (F) actin 145(A5), (G) actin 295(A5), (H) actin 95(A5), and (I)
actin 350(A5). Left panels are phalloı¨din staining of the actin cy-
toskeleton, middle panels, anti-Myc-FITC staining of the expressed
mutants, right panels overlay (phalloı¨din 	 red, myc 	 green). (A)
and (B) are controls were one can observe incorporation of in vitro and in (C) and (D), the endogenous actin filamentous network is
copolymerizable Myc-tagged actins. For the mutants shown in (C)– even disturbed and cells loose their shape (see also more detailed
(G), Holmes contacts are disturbed and no incorporation of Myc- in Figure 6). The mutants shown in (H) and (I) incorporate in the
actin mutants is observed. In (C) and (E), transfected cells are smaller filaments which disagrees with the ribbon model. Scale bar	 40m.
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Figure 6. Introduction of Noncopolymerizing
Actin Mutants in Cells Has Drastic Effects on
the Cytoskeleton and Cell Shape
(A–C) Details of three different transfected
NIH3T3 cells with Myc-tagged actin mutants
60(A5), (A) is a detail of Figure 5C. Green is
anti-Myc, red is phalloı¨din, and blue is DAPI
staining (only in [C]). Actin filaments (red) ap-
pear as extranuclear short thick fibers, the
nucleus seems to be smaller and deformed.
(D–F) Detail of a cell transfected with Myc-
tagged actin 35(A5), (D) is phalloı¨din staining,
(E) is anti-Myc staining, and (F) is the overlay.
In all images the scale bar is 20 m.
Experimental Procedures Polymerization Assays
Twenty-five microliters of an in vitro transcription translation reac-
tion of wild-type or mutant -actin was centrifuged at 100,000 rpmConstruction of the -Actin Alanine Mutants
Alanine-scan mutants were made with the Quik Change site directed in a Beckman airfuge to remove aggregates. To the supernatant,
we added 25l of 12 M -actin (purified from rabbit skeletal musclemutagenesis kit (Stratagene) using human -actin in pcDNA3.1 (In-
vitrogen) as a template. The primers were designed in such a way according to Pardee and Spudich [1982]) in G buffer (2 mM Tris-HCl
[pH 8], 0.2 mM CaCl2, 0.5 mM DTT, 0.2 mM ATP), i.e., approximately athat five consecutive codons are changed to codons for alanine and
that a PstI restriction site is introduced. This enabled rapid checking 500-fold excess of -actin over mutant -actin. We adjusted the
buffer conditions to 100 mM KCl and 1 mM MgCl2 (F-buffer) andfor introduction of mutations. N-terminal Myc-tagged wild-type and
actin mutants were made by PCR using the actin-alanine mutants allowed the actin to polymerize for 2 hr at room temperature. F-actin
was pelleted by centrifugation at 100,000 rpm for 20 min. The super-in the pcDNA3.1 vector as template, a 5
 primer containing the myc-
sequence preceded by a HindIII site and a 3
 primer containing a natant was removed (supernatant 1), the pellet washed and resus-
pended in 80 l G buffer. Actin was allowed to depolymerize over-XbaI site. These fragments were ligated in HindIII-XbaI digested
pcDNA3.1. Constructs were sequenced at the 5
 and/or 3
 end of night at 4C. A second round of polymerization was induced for 2
hr. F-actin was again centrifuged at 100,000 rpm for 20 min, whichtheir coding sequence and the alanine-scan mutants at the site of
the introduced mutations. resulted in the final pellet from which the supernatant 2 was re-
moved. Aggregates, supernatant 1 and 2 and the final pellet were
analyzed on a 12.5% SDS-gel followed by auto radiography. TheExpression of Actin Alanine Mutants and Band-Shift Assays
with Actin Binding Proteins amount of 35S-labeled actin in each fraction was quantified using
phosphor imaging. All mutants were analyzed at least three times.We expressed the actin alanine mutants as 35S-labeled proteins
in in vitro transcription translation reactions in reticulocyte lysate
(Promega) according to the manufacturer’s instructions, using 0.02 In Vivo Localization
We transfected pcDNA3.1 vectors encoding N-terminally Myc-Ci 35S-methionine (ICN) and 200 ng DNA per 25 l reaction. After
incubation at 30C for 1.5 hr, we analyzed the reaction products on tagged -actin (wild-type or mutant) in NIH 3T3 fibroblast cells using
electroporation. Twenty-four hours after transfection, cells weredenaturing tricine gels (Schagger and von Jagow, 1987) and on
nondenaturing polyacrylamide gels according to Safer (1989) with washed with PBS and fixed with 3% paraformaldehyde, permeabil-
ized with 0.1% Triton X100 in PBS and incubated for 1 hr at roomATP, followed by auto radiography. To monitor CAP binding, ATP
was omitted from the gels. The amount of 35S-actin bound to CAP temperature with an anti-Myc-FITC antibody (Invitrogen) and phal-
loı¨din-alexa-red (Molecular Probes). In some cases, additional DAPIwas quantified by phosphor imaging (Typhoon 9200 variable mode
imager, Amersham Biosciences) and the ImageQuant software staining was applied (0.4 g/ml). Stained cells were examined using
a Zeiss Axioplan II epifluorescence microscope equipped with apackage. For the band-shift assays, 1 l of the respective actin
binding proteins was added to 3 l of the in vitro transcription X40 and a X63 objective. Images were taken using a cooled CCD
Axiocam Camera and KS100 software (Zeiss). Native gel analysistranslation reaction. After 1 min incubation the mixture was analyzed
on native gels with 200 M ATP, or in the case of adseverin with of in vitro transcription translation reactions of these N-terminally
tagged wild-type and mutant actins show they behave like their200M ATP and 200M Ca2. The final concentration of the respec-
tive actin binding proteins was 2 nM for DNase I, 12.5 nM for thy- nontagged versions.
mosin 4, and 1 nM for adseverin. These concentrations are the
minimal amounts of the actin binding proteins needed to cause a Acknowledgments
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